Veradigm Inc. (NASDAQ:MDRX – Get Free Report) has received a consensus rating of “Hold” from the five research firms that are presently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $11.25.
A number of brokerages have commented on MDRX. Deutsche Bank Aktiengesellschaft reiterated a “hold” rating and issued a $10.00 target price (down from $15.00) on shares of Veradigm in a report on Tuesday, March 19th. StockNews.com started coverage on Veradigm in a report on Wednesday, May 1st. They set a “hold” rating for the company. Finally, Royal Bank of Canada dropped their target price on Veradigm from $22.00 to $11.00 and set an “outperform” rating on the stock in a research note on Friday, January 19th.
Get Our Latest Research Report on MDRX
Institutional Trading of Veradigm
Veradigm Price Performance
MDRX opened at $7.70 on Tuesday. Veradigm has a 12 month low of $5.01 and a 12 month high of $14.09. The stock has a fifty day moving average price of $7.69 and a 200-day moving average price of $9.62.
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
See Also
- Five stocks we like better than Veradigm
- Using the MarketBeat Stock Split Calculator
- 3 CEO-Led Turnaround Stocks You Can Still Buy
- Airline Stocks – Top Airline Stocks to Buy Now
- 3 Value Stocks You Can Buy Before They Become Big
- Trading Halts Explained
- Chinese Stocks Stage Impressive Rebound
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.